Literature DB >> 18053808

Distinct association of SLC19A1 polymorphism -43T>C with red cell folate levels and of MTHFR polymorphism 677C>T with plasma folate levels.

Anthoula Chatzikyriakidou1, Konstantinos V Vakalis, Nicholas Kolaitis, Georgios Kolios, Katerina K Naka, Lampros K Michalis, Ioannis Georgiou.   

Abstract

OBJECTIVES: The role of SLC19A1 -43T>C, MTHFR 677C>T and MS 2756A>G polymorphisms on red cell and plasma folate levels. DESIGN AND METHODS: Genotype analysis of the three polymorphisms. Red cell and plasma folate measurements in 64 patients with coronary artery disease.
RESULTS: The non-wild type allele of SLC19A1 polymorphism -43T>C was associated with low red cell folate levels and the non-wild type allele of MTHFR polymorphism 677C>T with low plasma folate levels.
CONCLUSION: SLC19A1 and MTHFR genes are differently associated with red cell and plasma folate levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18053808     DOI: 10.1016/j.clinbiochem.2007.11.006

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  5 in total

1.  Association analyses suggest multiple interaction effects of the methylenetetrahydrofolate reductase polymorphisms on timing of menarche and natural menopause in white women.

Authors:  Pengyuan Liu; Yan Lu; Robert R Recker; Hong-Wen Deng; Volodymyr Dvornyk
Journal:  Menopause       Date:  2010 Jan-Feb       Impact factor: 2.953

2.  Genes involved with folate uptake and distribution and their association with colorectal cancer risk.

Authors:  Jane C Figueiredo; A Joan Levine; Won H Lee; David V Conti; Jenny N Poynter; Peter T Campbell; David Duggan; Juan Pablo Lewinger; Maria Elena Martinez; Cornelia M Ulrich; Polly Newcomb; John Potter; Paul J Limburg; John Hopper; Mark A Jenkins; Loic Le Marchand; John A Baron; Robert W Haile
Journal:  Cancer Causes Control       Date:  2009-12-27       Impact factor: 2.506

3.  Folate network genetic variation, plasma homocysteine, and global genomic methylation content: a genetic association study.

Authors:  Susan M Wernimont; Andrew G Clark; Patrick J Stover; Martin T Wells; Augusto A Litonjua; Scott T Weiss; J Michael Gaziano; Katherine L Tucker; Andrea Baccarelli; Joel Schwartz; Valentina Bollati; Patricia A Cassano
Journal:  BMC Med Genet       Date:  2011-11-21       Impact factor: 2.103

Review 4.  Pharmacogenomics with red cells: a model to study protein variants of drug transporter genes.

Authors:  Willy Albert Flegel; Kshitij Srivastava; Tristan Michael Sissung; Barry Ronald Goldspiel; William Douglas Figg
Journal:  Vox Sang       Date:  2020-09-30       Impact factor: 2.996

5.  Population Genetic Difference of Pharmacogenomic VIP Variants in the Tibetan Population.

Authors:  Chunjuan He; Linna Peng; Shishi Xing; Dandan Li; Li Wang; Tianbo Jin
Journal:  Pharmgenomics Pers Med       Date:  2021-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.